Cardiomyocyte VEGF Regulates Endothelial Cell GPIHBP1 to Relocate Lipoprotein Lipase to the Coronary Lumen during Diabetes Mellitus

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 36, Issue 1, 2016, Pages 145-155

  Chiu, Amy Pei Ling ^a   Wan, Andrea ^a   Lal, Nathaniel ^a   Zhang, Dahai ^a   Wang, Fulong ^a   Vlodavsky, Israel ^b   Hussein, Bahira ^a   Rodrigues, Brian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

heparanase; hyperglycemia; lipoprotein lipase; Notch; receptors; triglycerides

Indexed keywords

DELTA LIKE LIGAND 4; GLUCOSE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED HIGH DENSITY LIPOPROTEIN BINDING PROTEIN 1; HEPARANASE; LIGAND; LIPOPROTEIN LIPASE; LIPOPROTEIN RECEPTOR; MESSENGER RNA; NEUTRALIZING ANTIBODY; NOTCH RECEPTOR; RECOMBINANT VASCULOTROPIN; UNCLASSIFIED DRUG; VASCULOTROPIN; BETA GLUCURONIDASE; GLUCOSE BLOOD LEVEL; GPIHBP1 PROTEIN, RAT; MEMBRANE PROTEIN; PROTEIN; SIGNAL PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME RELEASE; GENE EXPRESSION; HEART MUSCLE CELL; HYPERGLYCEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; CARDIAC MUSCLE CELL; CELL CULTURE; COCULTURE; CORONARY BLOOD VESSEL; ENERGY METABOLISM; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENETICS; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; PARACRINE SIGNALING; PROTEIN TRANSPORT; TIME FACTOR; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CELLS, CULTURED; COCULTURE TECHNIQUES; CORONARY VESSELS; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIAL CELLS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GLUCURONIDASE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPROTEIN LIPASE; MALE; MEMBRANE PROTEINS; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; PROTEIN TRANSPORT; RATS, WISTAR; RECEPTORS, LIPOPROTEIN; RECEPTORS, NOTCH; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84952637038     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306774     Document Type: Article

References (43)

1. An D, Rodrigues B, Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006 291 H1489 H1506. doi: 10.1152/ajpheart.00278.2006
2. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC, Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010 90 207 258. doi: 10.1152/physrev.00015.2009
3. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess BO, Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994 1213 263 276
4. Haffner SM, Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance. Am J Cardiol 2002 90 8A 55i 61i
5. Merkel M, Eckel RH, Goldberg IJ, Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 2002 43 1997 2006
6. Voshol PJ, Rensen PC, van Dijk KW, Romijn JA, Havekes LM, Effect of plasma triglyceride metabolism on lipid storage in adipose tissue: studies using genetically engineered mouse models. Biochim Biophys Acta 2009 1791 479 485. doi: 10.1016/j.bbalip.2008.12.015
7. Coppiello G, Collantes M, Sirerol-Piquer MS, Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake. Circulation 2015 131 815 826. doi: 10.1161/CIRCULATIONAHA.114.013721
8. Eckel RH, Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989 320 1060 1068. doi: 10.1056/NEJM198904203201607
9. Young SG, Davies BS, Voss CV, Gin P, Weinstein MM, Tontonoz P, Reue K, Bensadoun A, Fong LG, Beigneux AP, GPIHBP1, an endothelial cell transporter for lipoprotein lipase. J Lipid Res 2011 52 1869 1884. doi: 10.1194/jlr.R018689
10. Davies BS, Beigneux AP, Barnes RH 2nd, Tu Y, Gin P, Weinstein MM, Nobumori C, Nyrén R, Goldberg I, Olivecrona G, Bensadoun A, Young SG, Fong LG, GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries. Cell Metab 2010 12 42 52. doi: 10.1016/j.cmet.2010.04.016
11. Rodrigues B, Cam MC, McNeill JH, Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol 1995 27 169 179
12. Pulinilkunnil T, Rodrigues B, Cardiac lipoprotein lipase: metabolic basis for diabetic heart disease. Cardiovasc Res 2006 69 329 340. doi: 10.1016/j.cardiores.2005.09.017
13. Kim MS, Wang Y, Rodrigues B, Lipoprotein lipase mediated fatty acid delivery and its impact in diabetic cardiomyopathy. Biochim Biophys Acta 2012 1821 800 808. doi: 10.1016/j.bbalip.2011.10.001
14. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A, Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res 2009 50 3 21. doi: 10.1194/jlr.R800031-JLR200
15. Rodrigues B, Cam MC, Jian K, Lim F, Sambandam N, Shepherd G, Differential effects of streptozotocin-induced diabetes on cardiac lipoprotein lipase activity. Diabetes 1997 46 1346 1353
16. Wang Y, Puthanveetil P, Wang F, Kim MS, Abrahani A, Rodrigues B, Severity of diabetes governs vascular lipoprotein lipase by affecting enzyme dimerization and disassembly. Diabetes 2011 60 2041 2050. doi: 10.2337/db11-0042
17. Kim MS, Kewalramani G, Puthanveetil P, Lee V, Kumar U, An D, Abrahani A, Rodrigues B, Acute diabetes moderates trafficking of cardiac lipoprotein lipase through p38 mitogen-activated protein kinase-dependent actin cytoskeleton organization. Diabetes 2008 57 64 76. doi: 10.2337/db07-0832
18. Wang F, Kim MS, Puthanveetil P, Kewalramani G, Deppe S, Ghosh S, Abrahani A, Rodrigues B, Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid. Am J Physiol Heart Circ Physiol 2009 296 H1108 H1116. doi: 10.1152/ajpheart.01312.2008
19. Pei-Ling Chiu A, Wang F, Lal N, Wang Y, Zhang D, Hussein B, Wan A, Vlodavsky I, Rodrigues B, Endothelial cells respond to hyperglycemia by increasing the LPL transporter GPIHBP1. Am J Physiol Endocrinol Metab 2014 306 E1274 E1283. doi: 10.1152/ajpendo.00007.2014
20. Chen J, Zheng D, Shen J, Ruan J, Li A, Li W, Xie G, Luo X, Zhao P, Zheng H, Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells. Oncol Rep 2013 29 1888 1894. doi: 10.3892/or.2013.2325
21. Iozzo RV, Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 2001 108 165 167. doi: 10.1172/JCI13560
22. Lee TY, Folkman J, Javaherian K, HSPG-binding peptide corresponding to the exon 6a-encoded domain of VEGF inhibits tumor growth by blocking angiogenesis in murine model. PLoS One 2010 5 e9945. doi: 10.1371/journal.pone.0009945
23. Bame KJ, Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans. Glycobiology 2001 11 91R 98R
24. Harjes U, Bridges E, McIntyre A, Fielding BA, Harris AL, Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells. J Biol Chem 2014 289 23168 23176. doi: 10.1074/jbc.M114.576512
25. Adeyo O, Goulbourne CN, Bensadoun A, Beigneux AP, Fong LG, Young SG, Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins. J Intern Med 2012 272 528 540. doi: 10.1111/joim.12003
26. Kopan R, Ilagan MX, The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009 137 216 233. doi: 10.1016/j.cell.2009.03.045
27. Bi P, Kuang S, Notch signaling as a novel regulator of metabolism. Trends Endocrinol Metab 2015 26 248 255. doi: 10.1016/j.tem.2015.02
28. Carmeliet P, Ng YS, Nuyens D, Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Nat Med 1999 5 495 502. doi: 10.1038/8379
29. Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, Hanley A, Isner JM, Losordo DW, Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 2005 111 2073 2085. doi: 10.1161/01.CIR.0000162472.52990.36
30. Augustus AS, Kako Y, Yagyu H, Goldberg IJ, Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab 2003 284 E331 E339. doi: 10.1152/ajpendo.00298.2002
31. Creager MA, Lüscher TF, Cosentino F, Beckman JA, Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Circulation 2003 108 1527 1532. doi: 10.1161/01.CIR.0000091257.27563.32
32. Schubert SY, Ilan N, Shushy M, Ben-Izhak O, Vlodavsky I, Goldshmidt O, Human heparanase nuclear localization and enzymatic activity. Lab Invest 2004 84 535 544. doi: 10.1038/labinvest.3700084
33. Zhang D, Wan A, Chiu AP, Wang Y, Wang F, Neumaier K, Lal N, Bround MJ, Johnson JD, Vlodavsky I, Rodrigues B, Hyperglycemia-induced secretion of endothelial heparanase stimulates a vascular endothelial growth factor autocrine network in cardiomyocytes that promotes recruitment of lipoprotein lipase. Arterioscler Thromb Vasc Biol 2013 33 2830 2838. doi: 10.1161/ATVBAHA.113.302222
34. Iozzo RV, San Antonio JD, Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 2001 108 349 355. doi: 10.1172/JCI13738
35. Selvaraju V, Joshi M, Suresh S, Sanchez JA, Maulik N, Maulik G, Diabetes, oxidative stress, molecular mechanism, and cardiovascular disease-an overview. Toxicol Mech Methods 2012 22 330 335. doi: 10.3109/15376516.2012.666648
36. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, King GL, Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 2002 105 373 379
37. Kim MS, Wang F, Puthanveetil P, Kewalramani G, Innis S, Marzban L, Steinberg SF, Webber TD, Kieffer TJ, Abrahani A, Rodrigues B, Cleavage of protein kinase D after acute hypoinsulinemia prevents excessive lipoprotein lipase-mediated cardiac triglyceride accumulation. Diabetes 2009 58 2464 2475. doi: 10.2337/db09-0681
38. Bertoni AG, Tsai A, Kasper EK, Brancati FL, Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 2003 26 2791 2795
39. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG, Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001 24 5 10
40. Struthers AD, Morris AD, Screening for and treating left-ventricular abnormalities in diabetes mellitus: a new way of reducing cardiac deaths. Lancet 2002 359 1430 1432. doi: 10.1016/S0140-6736(02)08358-7
41. Augustus A, Yagyu H, Haemmerle G, Bensadoun A, Vikramadithyan RK, Park SY, Kim JK, Zechner R, Goldberg IJ, Cardiac-specific knock-out of lipoprotein lipase alters plasma lipoprotein triglyceride metabolism and cardiac gene expression. J Biol Chem 2004 279 25050 25057. doi: 10.1074/jbc.M401028200
42. Augustus AS, Buchanan J, Park TS, Hirata K, Noh HL, Sun J, Homma S, D'armiento J, Abel ED, Goldberg IJ, Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem 2006 281 8716 8723. doi: 10.1074/jbc.M509890200
43. Noh HL, Okajima K, Molkentin JD, Homma S, Homma S, Goldberg IJ, Acute lipoprotein lipase deletion in adult mice leads to dyslipidemia and cardiac dysfunction. Am J Physiol Endocrinol Metab 2006 291 E755 E760. doi: 10.1152/ajpendo.00111.2006